Published in Br J Dermatol on October 01, 1984
Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child (1990) 8.62
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc (2012) 3.60
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut (2003) 3.30
Recent advances in coeliac disease. Gut (2006) 3.20
Endomysial antibody: is it the best screening test for coeliac disease? Gut (1992) 1.93
Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med (2002) 1.75
Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis. Gut (1989) 1.65
Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child (1991) 1.61
Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut (1994) 1.57
Endomysium antibodies in coeliac disease: an improved method. Gut (1994) 1.54
Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol (2013) 1.53
Gamma/delta T cells and the diagnosis of coeliac disease. Clin Exp Immunol (1991) 1.51
Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study. Clin Gastroenterol Hepatol (2015) 1.40
Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol (2008) 1.38
Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy. BMJ (1991) 1.34
ACP Broadsheet No 149: September 1996. Serological diagnosis of gluten sensitive enteropathy. J Clin Pathol (1996) 1.33
Immunoglobulin A (IgA) deficiency and alternative celiac disease-associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing. Clin Diagn Lab Immunol (2000) 1.02
Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease. Gut (1992) 1.00
Anti-endomysial antibody negative celiac disease: does additional serological testing help? Dig Dis Sci (2001) 0.99
Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group. Dig Dis Sci (1999) 0.97
The adaptive immune response in celiac disease. Semin Immunopathol (2012) 0.97
IgA anti-endomysial antibody detection in the serum of patients with dermatitis herpetiformis following gluten challenge. Arch Dermatol Res (1985) 0.97
Bone-specific antibodies in sera from patients with celiac disease: characterization and implications in osteoporosis. J Clin Immunol (2002) 0.90
Diagnosis of celiac disease. Gastrointest Endosc Clin N Am (2012) 0.88
Impact of mass screening for gluten-sensitive enteropathy in working population. World J Gastroenterol (2009) 0.87
Distribution of monkey esophagus antigens reactive with IgA-class antibodies in the sera of dermatitis herpetiformis patients. Arch Dermatol Res (1984) 0.83
Assessing of Celiac Disease and Nonceliac Gluten Sensitivity. Gastroenterol Res Pract (2015) 0.83
Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory. Auto Immun Highlights (2012) 0.82
Extracts of wheat gluten activate complement via the alternative pathway. Clin Exp Immunol (1993) 0.78
Salivary IgA antigliadin antibody as a marker for coeliac disease. Arch Dis Child (1992) 0.78
Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea. Frontline Gastroenterol (2010) 0.78
Testing for antireticulin antibodies in patients with celiac disease is obsolete: a review of recommendations for serologic screening and the literature. Clin Vaccine Immunol (2013) 0.75
Simultaneous detection of celiac disease-specific IgA antibodies and total IgA. Auto Immun Highlights (2016) 0.75
Hepatobiliary disorders in celiac disease: an update. Int J Hepatol (2010) 0.75
Monozygous twins concordant for duodenojejunal villous atrophy and dermatitis herpetiformis. Gut (1986) 0.75
Antiendomysial antibody--useful serological indicator of dermatitis herpetiformis. Arch Dermatol Res (1987) 0.75
Prevalence and Morbidity of Undiagnosed Celiac Disease From a Community-based Study. Gastroenterology (2016) 0.75
Omitting duodenal biopsy in children with suspected celiac disease and extra-intestinal symptoms. Ital J Pediatr (2017) 0.75
Estimation of serum beta-2-microglobulin in children with malabsorption disorders syndrome. J Gastroenterol (1997) 0.75
Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology. Clin Rev Allergy Immunol (2017) 0.75
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (1986) 11.35
Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J (1986) 6.08
Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 4.93
The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J (1986) 4.47
Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell (1988) 4.47
Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J (1997) 4.07
Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A (1998) 3.72
Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell (2000) 3.47
Identification of papillomaviruses in butchers' warts. J Invest Dermatol (1981) 3.00
Rates, timing and causes of neonatal deaths in rural India: implications for neonatal health programmes. Bull World Health Organ (2006) 2.90
A novel type of human papillomavirus associated with genital neoplasias. Nature (1986) 2.89
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature (1989) 2.82
Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv (2000) 2.77
Quantitative studies of immunofluorescent staining. Relationships of characteristics of unabsorbed antihuman IgG conjugates to their specific and non-specific staining properties in an indirect test for antinuclear factors. Bull World Health Organ (1968) 2.72
Efficacy, efficiency and safety aspects of hydrogen peroxide vapour and aerosolized hydrogen peroxide room disinfection systems. J Hosp Infect (2012) 2.71
Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66
The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J Immunol (1986) 2.48
2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med (1998) 2.48
Natural killer cells: definition of a cell type rather than a function. J Immunol (1986) 2.46
Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts. J Exp Med (1989) 2.45
Incidence of celiac disease identified by the presence of serum endomysial antibodies in children with chronic diarrhea, short stature, or insulin-dependent diabetes mellitus. J Pediatr (1993) 2.44
[Not Available]. J Minim Access Surg (2008) 2.41
Quantitative studies of immunofluorescent staining. I. Analyses of mixed immunofluorescence. Immunology (1967) 2.32
Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci U S A (1998) 2.32
Perforin: more than just an effector molecule. Immunol Today (2000) 2.30
Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med (2001) 2.30
Pharmacognostic study and anti-inflammatory activity of Callistemon lanceolatus leaf. Asian Pac J Trop Biomed (2011) 2.30
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29
The N-terminal DNA-binding 'zinc finger' of the oestrogen and glucocorticoid receptors determines target gene specificity. EMBO J (1988) 2.28
Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci U S A (1978) 2.26
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Introduction of community-based skin-to-skin care in rural Uttar Pradesh, India. J Perinatol (2006) 2.16
Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J (2000) 2.13
A detailed genetic map for the X chromosome of the malaria vector, Anopheles gambiae. Science (1993) 2.10
Sequence of a cDNA from the mosquito Anopheles gambiae encoding a homologue of human ribosomal protein S7. Nucleic Acids Res (1993) 2.07
Nutritional status of preschool Mexican-American migrant farm children. Am J Dis Child (1971) 2.06
The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Res (1989) 2.05
Preliminary, dermatologic first step criteria for lupus erythematosus and second step criteria for systemic lupus erythematosus. Int J Dermatol (1993) 2.05
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet (2003) 2.04
Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant (2015) 2.03
Human papillomaviruses associated with epidermodysplasia verruciformis. II. Molecular cloning and biochemical characterization of human papillomavirus 3a, 8, 10, and 12 genomes. J Virol (1983) 2.01
Current global status of carotid artery stent placement. Cathet Cardiovasc Diagn (1998) 1.99
A new fluorescent antibody method: mixed antiglobulin immunofluorescence or labelled antigen indirect immunofluorescence staining. Nature (1965) 1.98
A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem (1998) 1.98
Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med (1987) 1.95
Clinical significance of autoantibodies in pemphigus. Arch Dermatol (1966) 1.95
Anvirzel, an extract of Nerium oleander, induces cell death in human but not murine cancer cells. Anticancer Drugs (2000) 1.95
Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res (1972) 1.91
Murine natural killer cells and marrow graft rejection. Annu Rev Immunol (1992) 1.87
Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol (1993) 1.87
Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene (1997) 1.85
The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity (1996) 1.84
Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83
Vector control in leishmaniasis. Indian J Med Res (2006) 1.81
Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J Virol (1984) 1.78
Studies in immunodermatology. VI. IF studies of autoantibodies to the stratum corneum and of in vivo fixed IgG in stratum corneum of psoriatic lesions. Int Arch Allergy Appl Immunol (1975) 1.77
Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol (1999) 1.77
Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol (1998) 1.77
The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival. Am J Transplant (2012) 1.73
Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res (1979) 1.73
Vitamin B12 deficiency presenting as pyrexia. J Assoc Physicians India (2011) 1.68
Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population. Gut (2011) 1.65
A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis. Int J Parasitol (1992) 1.65
Paediatricians' knowledge of cardiac arrest guidelines. Arch Dis Child (1996) 1.61
A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol (1993) 1.61
Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem/Hb uptake systems of pathogenic bacteria. Mol Microbiol (1999) 1.61
IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci (1983) 1.59
Biochemical characterization of two types of human papillomaviruses associated with epidermodysplasia verruciformis. J Virol (1982) 1.58
Autoimmunity in chronic bullous skin diseases. Immunofluorescent demonstration of three types of antibodies to skin in sera of patients with pemphigus, bullous pemphigoid and in other human sera. Clin Exp Immunol (1967) 1.58
Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. J Immunol (1993) 1.57
Ultrastructural localization of immunoglobulins in bullous pemphigoid skin. Employment of a new peroxidase-antiperoxidase multistep method. J Invest Dermatol (1975) 1.57
Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med (1987) 1.56
Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. J Immunol (1983) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur J Immunol (1988) 1.55
Bromocriptine: a novel approach to the treatment of type 2 diabetes. Diabetes Care (2000) 1.55
Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis. Ann Trop Med Parasitol (2002) 1.54
Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. Proc Natl Acad Sci U S A (1986) 1.54
Validation of causes of infant death in the community by verbal autopsy. Indian J Pediatr (1988) 1.54
Maternal mortality inquiry in a rural community of north India. Int J Gynaecol Obstet (1989) 1.53
Studies in immunodermatology. VII. Four-compartment system studies of IgG in stratum corneum and of stratum corneum antigen in biopsies of psoriasis and control dermatoses. Int Arch Allergy Appl Immunol (1975) 1.52
Microscopic evaluation and physiochemical analysis of Dillenia indica leaf. Asian Pac J Trop Biomed (2011) 1.51
A pilot study on the role of T-tube in typhoid ileal perforation in children. World J Surg (2008) 1.51
Synovial schistosomiasis of the hip. J Bone Joint Surg Br (1993) 1.51
Intraoperative floppy iris syndrome with doxazosin. Eye (Lond) (2007) 1.50
Management of birth asphyxia by traditional birth attendants. World Health Forum (1989) 1.49
Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells. J Immunol (1986) 1.48